Literature DB >> 25761617

Clinical utility of screening for CALR gene exon 9 mutations in patients with splanchnic venous thrombosis.

Donatella Colaizzo, Lucio Amitrano, Maria Anna Guardascione, Giovanni Favuzzi, Giovanni Luca Tiscia, Giovanna D'Andrea, Rosa Santacroce, Elvira Grandone, Maurizio Margaglione1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25761617     DOI： 10.1160/TH14-12-1055

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  4 in total

Review 1.  Splanchnic vein thrombosis in myeloproliferative neoplasms: pathophysiology and molecular mechanisms of disease.

Authors:  Joan How; Amy Zhou; Stephen T Oh
Journal:  Ther Adv Hematol       Date:  2016-12-08

2.  Esophageal location of mantle cell lymphoma.

Authors:  Spyros Michopoulos
Journal:  Ann Gastroenterol       Date:  2016-09-06

3.  CALR mutation analysis is not indicated in patients with splanchnic vein thrombosis without evidence of a myeloproliferative neoplasm: a micro-review.

Authors:  Stephen E Langabeer
Journal:  Ann Gastroenterol       Date:  2016-06-10

4.  Detecting CALR Mutations in Splanchnic Vein Thrombosis: Who and How?

Authors:  Stephen E Langabeer
Journal:  J Transl Int Med       Date:  2018-06-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.